Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.450
-0.010 (-0.68%)
At close: Nov 5, 2025, 4:00 PM EST
1.510
+0.060 (4.14%)
After-hours: Nov 5, 2025, 7:59 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $271.54 million as of November 5, 2025. Its market cap has decreased by -59.33% in one year.
Market Cap
271.54M
Enterprise Value
317.48M
1-Year Change
-59.33%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $271.54M, an increase of 118.44%. That is a compound annual growth rate of 17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 271.54M | -58.21% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
| Dec 1, 2020 | 124.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |